Physician
Retina & Uveitis Consultants of Maine
Retina & Uveitis Consultants of Maine was paid $384K by Medicaid between Jan 2018 and Dec 2024, across 28 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 34% of everything it billed.
33Billing provider infoRETINA & UVEITIS CONSULTANTS OF MAINE
BANGOR, ME 04401
BANGOR, ME 04401
33aNPI1487182580assigned 06/01/2017
28Total paid$384K
24GClaims43,586
24DCodes billed28
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,043 | $31K | |
| 2019 | 7,324 | $46K | |
| 2020 | 6,757 | $64K | |
| 2021 | 7,044 | $70K | |
| 2022 | 5,262 | $101K | |
| 2023 | 5,388 | $37K | |
| 2024incomplete | 5,768 | $35K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 34% | 6,112 | 3,100 | $130K |
| J9035 | Injection, bevacizumab, 10 mg | 17% | 4,149 | 2,259 | $66K |
| 92134 | 17% | 7,139 | 3,776 | $64K | |
| J0178 | Injection, aflibercept, 1 mg | 12% | 98 | 55 | $47K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 11% | 1,879 | 1,119 | $41K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 7.1% | 1,828 | 1,085 | $27K |
| 92250 | 1.6% | 801 | 481 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 92 | 57 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 21 | 13 | $790.06 |
| 92235 | <1% | 17 | 12 | $393.46 | |
| 2022F | <1% | 264 | 158 | $4.81 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | <1% | 1,669 | 1,011 | $4.81 |
16 more codes
| 2021F | <1% | 257 | $4.81 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 617 | $4.81 |
| 5010F | <1% | 257 | $4.81 | |
| 1036F | <1% | 3,429 | $4.81 | |
| G8756 | No documentation of blood pressure measurement, reason not given | <1% | 1,446 | $4.81 |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | <1% | 257 | $4.81 |
| G8785 | Blood pressure reading not documented, reason not given | 0% | 1,187 | $0.00 |
| 4040F | 0% | 3,329 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 2,216 | $0.00 |
| G9974 | Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity | 0% | 135 | $0.00 |
| 4004F | 0% | 15 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 3,085 | $0.00 |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 3,122 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 15 | $0.00 |
| 4177F | 0% | 133 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEKONG, ANTHONY (SOLE OWNER)